Review Frontiers in immunology · 2026 Research progress on the role of gut microbiota dysbiosis in the pathogenesis of immune-mediated liver diseases. Chen Y, Wang Z, Zeng Y, et al. Klebsiella pneumoniae PubMed ↗
Review Acta gastro-enterologica Belgica · 2025 The Potential Benefits of Akkermansia muciniphila as a Next-Generation Probiotic in the Maintenance of Overall Liver Health. Rachwal K, Mierczak K, Poplawski T Akkermansia muciniphila PubMed ↗
Systematic review Molecular nutrition & food research · 2023 Akkermansia muciniphila and Alcohol-Related Liver Diseases. A Systematic Review. Sparfel L, Ratodiarivony S, Boutet-Robinet E, et al. Akkermansia muciniphila PubMed ↗
Review American journal of transplantation · 2023 Impact of gut microbiota on liver transplantation. Sucu S, Basarir KE, Mihaylov P, et al. Faecalibacterium prausnitzii PubMed ↗
EMBO molecular medicine · 2026 Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease. Plazzo AP, Filz V, Prothiwa M, et al. Bifidobacterium animalis PubMed ↗
Journal of translational medicine · 2026 Dynamic gut microbiota shift in chronic liver disease progression: machine learning models and the E/Er ratio as a predictive biomarker. Mengting D, Zhaoyang J, Jingjing D, et al. [Clostridium] leptumAgathobacter rectalisFaecalibacterium prausnitzii PubMed ↗
Pediatric allergy and immunology · 2026 Functional changes in the gut microbiota are associated with the intestinal phenotype in A20 haploinsufficiency. Elhani I, Bredon M, Enea D, et al. Mediterraneibacter gnavus PubMed ↗
Nature microbiology · 2025 Microbial collagenase activity is linked to oral-gut translocation in advanced chronic liver disease. Jin S, Cenier A, Wetzel D, et al. Veillonella parvula PubMed ↗
Advanced science · 2024 Gut Commensal Barnesiella Intestinihominis Ameliorates Hyperglycemia and Liver Metabolic Disorders. Zhang Y, Xu D, Cai X, et al. Barnesiella intestinihominis PubMed ↗
Cell · 2024 A microbial-derived succinylated bile acid to safeguard liver health. Perino A, Demagny H, Schoonjans K Akkermansia muciniphila PubMed ↗
Journal of cystic fibrosis · 2024 Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor. Duong JT, Pope CE, Hayden HS, et al. Streptococcus salivariusVeillonella parvula PubMed ↗
Microbiology spectrum · 2023 Systemic multiomics evaluation of the therapeutic effect of Bacteroides species on liver cirrhosis in male mice. Park YR, Lee HL, Hyun JY, et al. Phocaeicola dorei PubMed ↗
European journal of gastroenterology & hepatology · 2023 Cultivation-based characterization of biliary microbiota in bile samples collected during routine endoscopic retrograde cholangiography: 10 years of experience at a tertiary center. Forster K, Klein F, Simon N, et al. Escherichia coli PubMed ↗
Microbes and infection · 2023 A novel gut microbiome-immune axis influencing pathology in HCMV infected infants with neonatal cholestasis. Karandikar K, Bhonde G, Palav H, et al. Bifidobacterium breveVeillonella dispar PubMed ↗
Gut microbes · 2022 Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury. Wang H, Wang Q, Yang C, et al. Bacteroides thetaiotaomicronBacteroides uniformisParabacteroides distasonisPhocaeicola dorei PubMed ↗
Microbiology spectrum · 2021 Dose-Dependent Relationship between Protection of Thioacetamide-Induced Acute Liver Injury and Hyperammonemia and Concentration of Lactobacillus salivarius Li01 in Mice. Lou P, Shen Y, Zhuge A, et al. Ligilactobacillus salivarius PubMed ↗
Nature cancer · 2021 Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis. Iida N, Mizukoshi E, Yamashita T, et al. Enterococcus faecalis PubMed ↗
Gut microbes · 2021 High alcohol-producing Klebsiella pneumoniae causes fatty liver disease through 2,3-butanediol fermentation pathway in vivo. Li NN, Li W, Feng JX, et al. Klebsiella pneumoniae PubMed ↗
Animal study Microbial biotechnology · 2023 Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids. Wu W, Kaicen W, Bian X, et al. Akkermansia muciniphila PubMed ↗
Animal study NPJ biofilms and microbiomes · 2023 Impaired flux of bile acids from the liver to the gut reveals microbiome-immune interactions associated with liver damage. Leung H, Xiong L, Ni Y, et al. Escherichia coli PubMed ↗